208 related articles for article (PubMed ID: 20547817)
1. Stereoselective phosphorylation of cyclopropavir by pUL97 and competitive inhibition by maribavir.
Gentry BG; Kamil JP; Coen DM; Zemlicka J; Drach JC
Antimicrob Agents Chemother; 2010 Aug; 54(8):3093-8. PubMed ID: 20547817
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of cyclopropavir and ganciclovir in human cytomegalovirus-infected cells.
Gentry BG; Drach JC
Antimicrob Agents Chemother; 2014; 58(4):2329-33. PubMed ID: 24514084
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of antiviral and endogenous nucleotides to di- and triphosphates by guanosine monophosphate kinase.
Gentry BG; Gentry SN; Jackson TL; Zemlicka J; Drach JC
Biochem Pharmacol; 2011 Jan; 81(1):43-9. PubMed ID: 20846508
[TBL] [Abstract][Full Text] [Related]
4. Resistance of human cytomegalovirus to cyclopropavir maps to a base pair deletion in the open reading frame of UL97.
Gentry BG; Vollmer LE; Hall ED; Borysko KZ; Zemlicka J; Kamil JP; Drach JC
Antimicrob Agents Chemother; 2013 Sep; 57(9):4343-8. PubMed ID: 23817384
[TBL] [Abstract][Full Text] [Related]
5. Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinase.
James SH; Hartline CB; Harden EA; Driebe EM; Schupp JM; Engelthaler DM; Keim PS; Bowlin TL; Kern ER; Prichard MN
Antimicrob Agents Chemother; 2011 Oct; 55(10):4682-91. PubMed ID: 21788463
[TBL] [Abstract][Full Text] [Related]
6. Potency and Stereoselectivity of Cyclopropavir Triphosphate Action on Human Cytomegalovirus DNA Polymerase.
Chen H; Li C; Zemlicka J; Gentry BG; Bowlin TL; Coen DM
Antimicrob Agents Chemother; 2016 Jul; 60(7):4176-82. PubMed ID: 27139481
[TBL] [Abstract][Full Text] [Related]
7. Comparison between human cytomegalovirus pUL97 and murine cytomegalovirus (MCMV) pM97 expressed by MCMV and vaccinia virus: pM97 does not confer ganciclovir sensitivity.
Wagner M; Michel D; Schaarschmidt P; Vaida B; Jonjic S; Messerle M; Mertens T; Koszinowski U
J Virol; 2000 Nov; 74(22):10729-36. PubMed ID: 11044117
[TBL] [Abstract][Full Text] [Related]
8. Differential properties of cytomegalovirus pUL97 kinase isoforms affect viral replication and maribavir susceptibility.
Webel R; Hakki M; Prichard MN; Rawlinson WD; Marschall M; Chou S
J Virol; 2014 May; 88(9):4776-85. PubMed ID: 24522923
[TBL] [Abstract][Full Text] [Related]
9. Functional regions of the human cytomegalovirus protein pUL97 involved in nuclear localization and phosphorylation of ganciclovir and pUL97 itself.
Michel D; Schaarschmidt P; Wunderlich K; Heuschmid M; Simoncini L; Mühlberger D; Zimmermann A; Pavić I; Mertens T
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2105-12. PubMed ID: 9747718
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of human cytomegalovirus replication drastically reduce the activity of the viral protein kinase pUL97.
Marschall M; Stein-Gerlach M; Freitag M; Kupfer R; van den Bogaard M; Stamminger T
J Gen Virol; 2001 Jun; 82(Pt 6):1439-1450. PubMed ID: 11369889
[TBL] [Abstract][Full Text] [Related]
11. Antagonistic Relationship between Human Cytomegalovirus pUL27 and pUL97 Activities during Infection.
Bigley TM; Reitsma JM; Terhune SS
J Virol; 2015 Oct; 89(20):10230-46. PubMed ID: 26223645
[TBL] [Abstract][Full Text] [Related]
12. The human cytomegalovirus UL97 protein is phosphorylated and a component of virions.
van Zeijl M; Fairhurst J; Baum EZ; Sun L; Jones TR
Virology; 1997 Apr; 231(1):72-80. PubMed ID: 9143304
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the UL97 ORF of ganciclovir-resistant clinical cytomegalovirus isolates differentially affect GCV phosphorylation as determined in a recombinant vaccinia virus system.
Baldanti F; Michel D; Simoncini L; Heuschmid M; Zimmermann A; Minisini R; Schaarschmidt P; Schmid T; Gerna G; Mertens T
Antiviral Res; 2002 Apr; 54(1):59-67. PubMed ID: 11888658
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of ganciclovir phosphonate by cellular GMP kinase determines the stereoselectivity of anti-human cytomegalovirus activity.
Miller WH; Beauchamp LM; Meade E; Reardon JE; Biron KK; Smith AA; Goss CA; Miller RL
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):341-56. PubMed ID: 10772719
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus.
O'Brien MS; Markovich KC; Selleseth D; DeVita AV; Sethna P; Gentry BG
Antiviral Res; 2018 Oct; 158():255-263. PubMed ID: 30153445
[TBL] [Abstract][Full Text] [Related]
16. Identification of inhibitors for a virally encoded protein kinase by 2 different screening systems: in vitro kinase assay and in-cell activity assay.
Mett H; Hölscher K; Degen H; Esdar C; De Neumann BF; Flicke B; Freudenreich T; Holzer G; Schinzel S; Stamminger T; Stein-Gerlach M; Marschall M; Herget T
J Biomol Screen; 2005 Feb; 10(1):36-45. PubMed ID: 15695342
[TBL] [Abstract][Full Text] [Related]
17. Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase.
Tenney DJ; Yamanaka G; Voss SM; Cianci CW; Tuomari AV; Sheaffer AK; Alam M; Colonno RJ
Antimicrob Agents Chemother; 1997 Dec; 41(12):2680-5. PubMed ID: 9420038
[TBL] [Abstract][Full Text] [Related]
18. Novel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity.
Herget T; Freitag M; Morbitzer M; Kupfer R; Stamminger T; Marschall M
Antimicrob Agents Chemother; 2004 Nov; 48(11):4154-62. PubMed ID: 15504835
[TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus pUL97 regulates the viral major immediate early promoter by phosphorylation-mediated disruption of histone deacetylase 1 binding.
Bigley TM; Reitsma JM; Mirza SP; Terhune SS
J Virol; 2013 Jul; 87(13):7393-408. PubMed ID: 23616659
[TBL] [Abstract][Full Text] [Related]
20. Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure.
Chou S; Marousek G; Bowlin TL
Antimicrob Agents Chemother; 2012 Jan; 56(1):197-201. PubMed ID: 21968367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
